A Diagnostics & Imaging Week
Inverness Medical Innovations (IMI; Waltham, Massachusetts) reported completing its acquisition of Panbio (Brisbane, Australia), that deal first disclosed last October. IMI acquired all outstanding shares for A$41 million (about $37 million).
Panbio makes tests for the diagnosis and management of infectious diseases. In particular, the company claims a leadership position in Dengue Fever diagnostics that will complement IMI’s product portfolio for the rapid diagnosis of blood-borne pathogens.
Panbio says it also provides “the Australian infrastructure required to support IMI’s plans for growth in the region.”
Solis Women’s Health (Austin, Texas) said it has acquired BenOra Imaging (Phoenix), which it says is the “oldest dedicated breast diagnostic facility in greater Phoenix, and a national pioneer in the delivery of women’s imaging.”
Financial terms of the deal were not disclosed.
Wayne Hansen, MD, Richard Vanesian, MD, and Michele West, MD, lead BenOra and will continue as principal physicians in the center, the company said.
Solis is a healthcare provider focused on the screening and diagnosis of breast cancer.
In other dealmaking activity: Research Corporation Technologies (RCT; Tucson, Arizona) said it has granted Biosound Esaote (Indianapolis) a non-exclusive license to patents that cover ultrasound tissue harmonic imaging (THI). Terms were not disclosed.
Biosound is a medical imaging company that says it specializes in “high-performance ultrasound systems.”
RCT manages the THI technology for its partner, the University of Rochester (Rochester, New York). Research by P. Ted Christopher, PhD, at the university’s Center for Biomedical Ultrasound resulted in a new mode of ultrasound imaging. Christopher’s invention showed that the second and higher-order harmonic response of native tissue to a propagated ultrasound beam could be employed to produce a sharper, higher-contrast image than that of the fundamental emitted frequency.
RCT received U.S. Patent No. 7,104,956, in September 2006; U.S. Patent No. 7,004,905 in February 2006; and U.S. Patent No. 6,206,833 in March 2001. Two other U.S. patents are pending.
Biosound joins Acuson (Malvern, Pennsylvania), a Siemens (Munich, Germany) company, Royal Philips Electronics (Amsterdam, the Netherlands) and GE Healthcare (Waukesha, Wisconsin) as a licensee of the THI technology.
RCT describes itself as a technology investment and management company that provides early-stage funding and development for biomedical companies and technologies from universities and research institutions worldwide.